CIK 0001582313 · Large accelerated filer
Xenon Pharmaceuticals Inc.
Sign in to watch- Ticker
- XENE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- EIN
- 980661854
- Phone
- (604) 484-3300
- Business address
- 200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
- Open-market buys, last 90 days
- $1,681,140
- in 2 filings
- Open-market sales, last 90 days
- $425,829
- in 1 filing, $426K under 10b5-1 plans
Net +$1,255,311. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-01 | MORTIMER IAN PRESIDENT, CEO & INTERIM CFO | Sale 10b5-1 | −25,000 | $40.16 | $1.0M | 31,302 |
| 2025-10-01 | MORTIMER IAN PRESIDENT, CEO & INTERIM CFO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −25,000 | 0 | ||
| 2025-06-23 | Cline Darren S Chief Commercial Officer | Grant or award · Share Option (Right to Buy) | +185,800 | 185,800 | ||
| 2025-06-05 | PATOU GARY Director | Grant or award · Share Option (Right to Buy) | +17,012 | 17,012 | ||
| 2025-06-05 | PATOU GARY Director | Grant or award · Restricted Share Units | +2,645 | 2,645 | ||
| 2025-06-05 | Machado Patrick Director | Grant or award · Share Option (Right to Buy) | +17,012 | 17,012 | ||
| 2025-06-05 | Machado Patrick Director | Grant or award · Restricted Share Units | +2,645 | 2,645 | ||
| 2025-06-05 | Gover Justin D. Director | Grant or award · Share Option (Right to Buy) | +17,012 | 17,012 | ||
| 2025-06-05 | Gover Justin D. Director | Grant or award · Restricted Share Units | +2,645 | 2,645 | ||
| 2025-06-05 | GAROFALO ELIZABETH A. Director | Grant or award · Share Option (Right to Buy) | +17,012 | 17,012 | ||
| 2025-06-05 | GAROFALO ELIZABETH A. Director | Grant or award · Restricted Share Units | +2,645 | 2,645 | ||
| 2025-06-05 | GANNON STEVEN Director | Sale | −3 | $30.48 | $91 | 7,141 |
| 2025-06-05 | GANNON STEVEN Director | Grant or award · Share Option (Right to Buy) | +17,012 | 17,012 | ||
| 2025-06-05 | GANNON STEVEN Director | Grant or award · Restricted Share Units | +2,645 | 2,645 | ||
| 2025-06-05 | Cannon Gillian Director | Grant or award · Share Option (Right to Buy) | +17,012 | 17,012 | ||
| 2025-06-05 | Cannon Gillian Director | Grant or award · Restricted Share Units | +2,645 | 2,645 | ||
| 2025-06-05 | Svoronos Dawn Director | Grant or award · Share Option (Right to Buy) | +17,012 | 17,012 | ||
| 2025-06-05 | Svoronos Dawn Director | Grant or award · Restricted Share Units | +2,645 | 2,645 | ||
| 2025-05-14 | GANNON STEVEN Director | Option exercise | +5,144 | $12.57 | $65K | 7,144 |
| 2025-05-14 | GANNON STEVEN Director | Option exercise · Stock Option (Right to Buy) | −5,144 | 0 |
Page 6 of 16 · 308 trades